Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
Postgrad Med · 2010
Last updated 2026-05-28People with severe insulin resistance often need 200 or more units of insulin daily to control their blood sugar. Losing weight can improve this condition but is difficult to achieve and maintain. Medications like metformin or thiazolidinediones may reduce insulin needs, while some patients still require high doses of insulin.
AI summary of the abstract below.
| Journal | Postgrad Med, 2010 |
|---|---|
| Citations | 8 |
| Relative citation ratio | 0.25 |
| NIH percentile | 16 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Abstract
The prevalence of obesity and diabetes is epidemic. Severe insulin resistance (defined as the need for > or = 200 units of insulin per day to achieve glycemic control) is commonly seen with obesity and can complicate diabetes management. The management of patients with diabetes who have severe insulin resistance is difficult, and at times frustrating, and requires a multifaceted approach. Weight loss is the best treatment option, which can be a challenging task for patients to achieve and maintain. Medications that decrease insulin needs like metformin, thiazolidinediones, or pramlintide may help, but some patients also need high doses of insulin. This article reviews these different treatment options and provides practical advice on weight loss, use of insulin sensitizers, and use of U-500 insulin.
Verbatim abstract via PubMed 20107300 ↗